Dosing Protocol
Typical Dose 100 mcg
Range 50 - 250 mcg
Pharmacokinetics
Half-Life 11 min
Onset 5 min
Peak 15 min
Duration 1.0 hrs
Bioavailability 95%
Primary Route Intravenous
Administration
Routes Intravenous, Subcutaneous
Injection Sites IV Infusion
Needle Gauge 25-27G
Syringe Type Standard
Timing Fasted, research protocol
Reconstitution
Diluent Sterile Saline
Volume 1 mL
Stability 1 days refrigerated
Special Instructions
Endogenous hormone - primarily research use. Acylated form required for receptor activity. Very short half-life requires IV infusion for sustained effects. Desacyl form is inactive at GHSR.